相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Should Treatment Indications for Chronic Hepatitis B Be Expanded?
Wen-Juei Jeng et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV co-infected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy
Amir M. Mohareb et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Extending treatment eligibility for chronic hepatitis B virus infection
Anna L. McNaughton et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
Mingjuan Tan et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada
Kyle A. Thompson et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP
Vita W. Jongen et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
Jia-Horng Kao et al.
HEPATOLOGY INTERNATIONAL (2021)
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
Grishma Hirode et al.
GASTROENTEROLOGY (2021)
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Raphael J. Landovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Health system adaptations and considerations to facilitate optimal oral pre-exposure prophylaxis scale-up in sub-Saharan Africa
Daniel K. Were et al.
LANCET HIV (2021)
Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies
Kathryn A Risher et al.
Lancet HIV (2021)
HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study
Christian Laurent et al.
LANCET HIV (2021)
The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India
Pooyan Kazemian et al.
CLINICAL INFECTIOUS DISEASES (2020)
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad
Marc G. Ghany et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Sexual health needs of female sex workers in Cote d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention
Valentine Becquet et al.
BMJ OPEN (2020)
Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya
Murithi Mbae et al.
AIDS (2019)
Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
Lauren M. K. Mason et al.
EUROSURVEILLANCE (2019)
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
Kin Seng Liem et al.
GUT (2019)
Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
Yun-Fan Liaw
HEPATOLOGY INTERNATIONAL (2019)
Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence
Bea Vuylsteke et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2019)
Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B
Joseph Larmarange et al.
AIDS (2018)
Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups
Abby May Falla et al.
BMC INFECTIOUS DISEASES (2018)
Less can be more: A finite treatment approach for HBeAg-negative chronic hepatitis B
Pietro Lampertico et al.
HEPATOLOGY (2018)
Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
Wen-Juei Jeng et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naive chronic hepatitis B: A case report and review of the literature
Woo Hee Cho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil
Paula M. Luz et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)
Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia
Hailemichael Desalegn et al.
BMC MEDICINE (2018)
Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
Nathan Ford et al.
HEPATOLOGY COMMUNICATIONS (2018)
Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication
Gerard-Menan Kouame et al.
CLINICAL INFECTIOUS DISEASES (2018)
No detectable resistance to tenofovir disoproxil fumarate in HBeAg plus and HBeAg- patients with chronic hepatitis B after 8years of treatment
Y. Liu et al.
JOURNAL OF VIRAL HEPATITIS (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study
Thomas Berg et al.
JOURNAL OF HEPATOLOGY (2017)
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mohsen Naghavi et al.
LANCET (2017)
Sexual partnership age pairings and risk of HIV acquisition in rural South Africa
Adam Akullian et al.
AIDS (2017)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
Anna S. F. Lok et al.
HEPATOLOGY (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
George Papatheodoridis et al.
HEPATOLOGY (2016)
The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
Marc M. Solomon et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
Jeanne M. Marrazzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
J. -M. Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis
Sundeep Goyal et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2015)
Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA
Henry L. Y. Chan et al.
GASTROENTEROLOGY (2014)
No Detectable Resistance to Tenofovir Disoproxil Fumarate After 6 Years of Therapy in Patients With Chronic Hepatitis B
Kathryn M. Kitrinos et al.
HEPATOLOGY (2014)
Patient preferences for hepatitis B therapy
Seng Gee Lim et al.
ANTIVIRAL THERAPY (2013)
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
Kachit Choopanya et al.
LANCET (2013)
The Cost-effectiveness of Pre-Exposure Prophylaxis for HIV Infection in South African Women
Rochelle P. Walensky et al.
CLINICAL INFECTIOUS DISEASES (2012)
First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice
S. Pol et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
J. M. Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral Therapy
Michael J. Mugavero et al.
CLINICAL INFECTIOUS DISEASES (2011)
Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention
Andrew Mujugira et al.
PLOS ONE (2011)
HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities
Catherine S. Todd et al.
AIDS (2010)
HIV and Hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis
Ethan Gough et al.
BMC PUBLIC HEALTH (2010)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hepatitis B and Human Immunodeficiency Virus Coinfection
Chloe L. Thio
HEPATOLOGY (2009)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Risk and predictors of mortality associated with chronic hepatitis B infection
Uchenna H. Iloeje et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabine
E Mondou et al.
CLINICAL INFECTIOUS DISEASES (2005)
Sexual transmission of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 infections among male transvestite comercial sex workers in Montevideo, Uruguay
JC Russi et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)